ALEXION PHARMACEUTICALS INC | 79,45 Euro | +1,05 +1,34 % | |
| WKN: 899527 ISIN: US0153511094 Ticker-Symbol: AXP | Frankfurt | 22.05.13 | 10:53 Uhr |
Branche PharmaAktienmarkt NASDAQ-100S&P 500 NASDAQ Biotech |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 13.05. | Alexion geht durch die Decke! | 66 | GodmodeTrader.de | |
| 10.05. | Shares of Alexion Pharmaceuticals Rank the Highest in Terms of P/E Ratio in the Biotechnology Industry | 18 | SmarTrend | |
| 07.05. | Alexion Pharmaceuticals Crosses Below its 10-day MA | 3 | SmarTrend | |
| 30.04. | ALEXION PHARMACEUTICALS INC - 10-Q, Quaterly Report | 8 | SEC Filings | |
| 29.04. | Alexion - Ziel erreicht, und nun? | 46 | GodmodeTrader.de | |
| 29.04. | Raised Guidance And Resolved Manufacturing Issues Support Alexion Shares | 3 | Seeking Alpha | |
| 26.04. | UBS erhöht das Kursziel für Alexion Pharma von $120 auf $123. | 139 | BörseGo | |
| UBS erhöht das Kursziel für Alexion Pharma von $120 auf $123.
(© BörseGo AG 2013 - Autor: Tobias Krieg, Redakteur) Mehr lesen zu: UBS erhöht das Kursziel für Alexion Pharma von $120 auf $123. | ||||
| 25.04. | ALEXION PHARMACEUTICALS INC - 8-K, Results of Operations and Financial Condition Financial ... | 12 | SEC Filings | |
| 25.04. | Alexion Soars on Q1 Results | 15 | Motley Fool | |
| 25.04. | Why Alexion Shares Popped | 13 | Motley Fool | |
| 25.04. | Bullish Moving Average Cross by Alexion Pharmaceuticals | 8 | SmarTrend | |
| 25.04. | Biogen, Alexion Earnings Look to Calm Biotech Investor Nerves | 9 | The Street | |
| 24.04. | Alexion - Rücksetzer bietet Einstiegsgelegenheit | 23 | GodmodeTrader.de | |
| 15.04. | Alexion Pharmaceuticals Crosses Below its 10-day MA | 12 | SmarTrend | |
| 15.04. | Insiders Buy Shares of Digital Generation and Goodrich Petroleum; Alexion Pharma's CEO Sells | 20 | Minyanville | |
| 10.04. | Alexion Pharmaceuticals has the Highest P/E Ratio in the Biotechnology Industry | 17 | SmarTrend | |
| 05.04. | Alexion's Manufacturing Concerns To Abate And Commercial Expansion To Drive Shares Higher | 15 | Seeking Alpha | |
| 01.04. | Bad News for Alexion, Shares Down | 52 | Zacks | |
| 28.03. | Buy Alexion on Weakness After FDA Warning Letter, Suggest Piper Jaffray Analyst | 22 | Benzinga.com | |
| 28.03. | Alexion Pharmaceuticals had the Lowest Relative Performance in the Healthcare Sector | 13 | SmarTrend | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| GILEAD SCIENCES | 43,702 | +0,14 % | Maximieren Sie Ihren Ertrag in nur 30 Minuten! (Freenet +370% / Technotrans +100% / Gilead +120% ...) |
| NOVO NORDISK | 133,55 | +0,49 % | Novo Nordisk and Paula Deen Announce Winners of the Seeing Diabetes in a New Light' Contest |
| CELESIO | 16,765 | +2,54 % | XFRA DIVIDEND INFORMATION - 17.05.2013 - 1 |
| VERTEX PHARMACEUTICALS | 62,11 | +1,14 % | Flagship Partners-backed Syros Pharma taps former Vertex vet as new CSO |
| CELGENE | 98,81 | +3,81 % | Nuvilex, Inc. and Celgene, Corp. Can Both Replace Eli Lilly's Cancer Drug Gemzar |
